Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?

Detalles Bibliográficos
Autores principales: Mary, Aurélien, Hénaut, Lucie, Schmit, Jean-Luc, Lanoix, Jean-Philippe, Brazier, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243823/
https://www.ncbi.nlm.nih.gov/pubmed/32574289
http://dx.doi.org/10.3389/fpubh.2020.00185
_version_ 1783537476914118656
author Mary, Aurélien
Hénaut, Lucie
Schmit, Jean-Luc
Lanoix, Jean-Philippe
Brazier, Michel
author_facet Mary, Aurélien
Hénaut, Lucie
Schmit, Jean-Luc
Lanoix, Jean-Philippe
Brazier, Michel
author_sort Mary, Aurélien
collection PubMed
description
format Online
Article
Text
id pubmed-7243823
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72438232020-06-03 Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy? Mary, Aurélien Hénaut, Lucie Schmit, Jean-Luc Lanoix, Jean-Philippe Brazier, Michel Front Public Health Public Health Frontiers Media S.A. 2020-05-15 /pmc/articles/PMC7243823/ /pubmed/32574289 http://dx.doi.org/10.3389/fpubh.2020.00185 Text en Copyright © 2020 Mary, Hénaut, Schmit, Lanoix and Brazier. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Mary, Aurélien
Hénaut, Lucie
Schmit, Jean-Luc
Lanoix, Jean-Philippe
Brazier, Michel
Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
title Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
title_full Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
title_fullStr Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
title_full_unstemmed Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
title_short Therapeutic Options for Coronavirus Disease 2019 (COVID-19) - Modulation of Type I Interferon Response as a Promising Strategy?
title_sort therapeutic options for coronavirus disease 2019 (covid-19) - modulation of type i interferon response as a promising strategy?
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243823/
https://www.ncbi.nlm.nih.gov/pubmed/32574289
http://dx.doi.org/10.3389/fpubh.2020.00185
work_keys_str_mv AT maryaurelien therapeuticoptionsforcoronavirusdisease2019covid19modulationoftypeiinterferonresponseasapromisingstrategy
AT henautlucie therapeuticoptionsforcoronavirusdisease2019covid19modulationoftypeiinterferonresponseasapromisingstrategy
AT schmitjeanluc therapeuticoptionsforcoronavirusdisease2019covid19modulationoftypeiinterferonresponseasapromisingstrategy
AT lanoixjeanphilippe therapeuticoptionsforcoronavirusdisease2019covid19modulationoftypeiinterferonresponseasapromisingstrategy
AT braziermichel therapeuticoptionsforcoronavirusdisease2019covid19modulationoftypeiinterferonresponseasapromisingstrategy

Ejemplares similares